Alport syndrome, recessive type
|
0.200 |
Biomarker
|
disease |
MGD |
Functional rescue of the glomerulosclerosis phenotype in Mpv17 mice by transgenesis with the human Mpv17 homologue.
|
7564095 |
1995 |
Alport syndrome, recessive type
|
0.200 |
Biomarker
|
disease |
MGD |
Early-onset liver mtDNA depletion and late-onset proteinuric nephropathy in Mpv17 knockout mice.
|
18818194 |
2009 |
Alport syndrome, recessive type
|
0.200 |
Biomarker
|
disease |
MGD |
Glomerular overproduction of oxygen radicals in Mpv17 gene-inactivated mice causes podocyte foot process flattening and proteinuria: A model of steroid-resistant nephrosis sensitive to radical scavenger therapy.
|
10233845 |
1999 |
Alport syndrome, recessive type
|
0.200 |
Biomarker
|
disease |
MGD |
Age-dependent hypertension in Mpv17-deficient mice, a transgenic model of glomerulosclerosis and inner ear disease.
|
10673153 |
1999 |
Amyloidosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Glomerulosclerosis was not correlated with adrenal morphology and neither kidney nor liver amyloidosis contributed significantly to variation in AW or ACMR on multivariate analyses.
|
28026881 |
2017 |
Anisocoria
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Anisocoria
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Arteriolar hyalinosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
DM was significantly associated with decrease in percent eGFR (p<0.05) and increase in arteriolar hyalinosis (p=0.004), Glomerulosclerosis (p=0.03) and Interstitial fibrosis/ Tubular atrophy (p=.0001).
|
28379664 |
2017 |
Arteriolosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Glomerulosclerosis and arteriolosclerosis scores were significantly lower (p<0.001) in the RMR+CAA group when compared with the RMR group.
|
29032332 |
2017 |
Arteriosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Glomerulosclerosis associated more strongly with arteriosclerosis and ischemic-appearing glomeruli in the superficial region.
|
31278193 |
2019 |
Arthritis, Gouty
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations.
|
23263486 |
2013 |
Ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Axonal neuropathy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
This report provides further evidence that MPV17 mutations should be considered in patients with pure, non-syndromic axonal neuropathy.
|
30298599 |
2019 |
Blepharoptosis
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Blepharoptosis
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Broad-based gait
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Broad-based gait
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Cholestasis
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
We identified pathogenic MPV17 and DGUOK mutations in 11 infants (6 females) representing 2.5% of the 450 cases of infantile cholestasis and 22% of the 50 cases of infantile liver failure referred to our center during the study period.
|
24321534 |
2014 |
Cholestasis
|
0.310 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Hepatocerebral form of mitochondrial DNA depletion syndrome: novel MPV17 mutations.
|
18695062 |
2008 |
Cirrhosis
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Cirrhosis
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
In spite of severe mtDNA depletion, only moderate decrease in respiratory chain enzymatic activities, and mild cytoarchitectural alterations, were observed in the Mpv17(-/-) livers, but neither cirrhosis nor failure ever occurred in this organ at any age.
|
18818194 |
2009 |
Cochlear Diseases
|
0.300 |
Biomarker
|
group |
CTD_human |
Early-onset liver mtDNA depletion and late-onset proteinuric nephropathy in Mpv17 knockout mice.
|
18818194 |
2009 |
COENZYME Q10 DEFICIENCY
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The most recently described mitochondrial myopathies are due to defects in nuclear DNA, including coenzyme Q10 deficiency and mutations in genes controlling mitochondrial DNA abundance and structure, such as POLG, TK2, and MPV17.
|
17053512 |
2006 |
Decreased distal sensory nerve action potential
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Decreased number of peripheral myelinated nerve fibers
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|